Growth Dynamics in the Biomedical/Biotechnology System |
| |
Authors: | Çetindamar Dilek Laage-Hellman Jens |
| |
Affiliation: | (1) Graduate School of Management, Sabanci University Tuzla, 81474 Istanbul, Turkey;(2) Department of Industrial Marketing, Chalmers University of Technology, SE-412 96 Gothenburg, Sweden E-mail |
| |
Abstract: | This article aims to understand the dynamics of growth in the biomedical/biotechnology system that consists of a variety of actors ranging from universities, medical supplies firms, and drug research firms, to clinical service suppliers. Based on a comparative study made in Ohio and in Sweden, we have analyzed three main factors: technology competencies, technology transfer, and networking capabilities. Our findings show a set of differences that can be grouped into two categories, viz. management and agglomeration externalities. Differences in management appear at three points: the resources allocated to technological competence development, managerial skills in the technology transfer phase, and the use of technology councils. Ohio seems to offer a better environment for starting up new firms and enabling these firms to successfully commercialize their technological assets. The agglomeration externalities that make a difference between the two regions might be grouped into two categories: increasing returns arising from network externalities and the advantages of networking with a variety of supporting organizations in the system. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|